News Update on Global Treatment for Syndromes of Dementia and Movement Disorders Market: Majorly Propelled by Rising Geriatric Population

According to the latest report, published by Variant Market Research, Global Treatment for Syndromes of Dementia and Movement Disorders Market size is estimated to reach $28.6 Billion by 2024 from $14.5 Billion in 2016, growing at a CAGR of 8.9% from 2016 to 2024.
Increasing rate of neurodegenerative disorders drives the global market
Rising geriatric population, increasing rate of neurodegenerative disorders, and growing investments in R&D are the primary factors to boost the global treatment for syndromes of dementia and movement disorders market. However, long approval time for drugs and devices is the major hindrance for the market growth. Furthermore, untapped markets particularly in emerging economies are expected to gain significant impetus in the coming future.
Market Segmentation
The global market is mainly classified on the basis of type and geography. The type segment includes progressive dementia (frontotemporal dementia/pick,Lewy body dementia,Alzheimer’s disease,and others), movement disorder (multiple system atrophy,progressive supranuclear palsy,Parkinson’s disease,hallervorden-spatz diseaseand others), and progressive dementia with neurological abnormality PDNA (corticobasal ganglionic degeneration,Huntington’s disease, and amyotrophic lateral sclerosis(ALS). Furthermore, by geography the global marketis categorized into North America, Europe, Asia-Pacific, and Rest of the World. U.S., Canada, and Mexico are covered under North America, whereas Europe segment includes of Spain, Italy, France, Germany, UK, and Rest of Europe. Asia-Pacific is segmented into China, Japan, Indiaand Rest of Asia-Pacific, while RoW is segmented into Middle East, South America, and Africa.
Progressive dementia, by type, dominated the segment with largest share in 2016
Progressive dementia accounted for the major share in 2016, in the type segment, and is also expected to continue its trend during the forecast period owing to large number of aging population and increasing incidence of neurodegenerative diseases.
North America lead the global market with highest share in 2016
In 2016, North America generated the highest revenue accounting for 42.2% of the total market share driven by increasing R&D, growing geriatric population, and unhealthy lifestyles. Europe occupied the second largest market share accounting for 25.8%. Asia-Pacific is likely to reach the fastest CAGR driven by increasing knowledge and expanding health care facilities, and presence of large population.
Competitive Landscape
Key players operating in the market include AstraZeneca GmbH,Valeant Pharmaceutical International, F. Hoffmann-La Roche, AG, Merck & Co., Inc., Abbott Laboratories, Inc.,  Novartis AS, Baxter International, Inc., Bristol-Myers Squibb, Pfizer, Inc., and Sanofi S.A., among others.
Scope of the Global Treatment for Syndromes of Dementia and Movement Disorders Market
Type Segments
  • Movement Disorders
    • Parkinson’s Disease
    • Progressive Supranuclear Palsy
    • Multiple System Atrophy
    • Hallervorden-Spatz Disease
    • Others 
  • Progressive Dementia

    • Alzheimer’s Disease
    • Lewy Body Dementia
    • Frontotemporal Dementia/Pick
    • Others
  • Progressive Dementia with Neurological Abnormality (PDNA)

    • Huntington’s Disease
    • Corticobasal Ganglionic Degeneration
    • Amyotrophic Lateral Sclerosis (ALS)
Geography Segments
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • Italy
    • UK
    • France
    • Spain
    • Others
  • Asia-Pacific
    • Japan
    • China
    • India
    • Others
  • RoW
    • South America
    • Middle East
    • Africa
About Variant Market Research
Variant Market Research offers syndicated and customized reports to fulfill clients' objectives. We also provide customized data pack proposing market sizing in an Excel/PDF/PowerPoint or Word format as per the requirement of clients. We cover several industry domains, namely Semiconductor & Electronics, Consumer Electronics, Information and Communication Technology, Automotive, Consumer Goods, Food & Beverages, Pharmaceuticals, Medical Devices, Chemicals, Industrial, Mining Equipment, Automation, Manufacturing, Construction, Energy & Power, Defense & Aerospace and Banking, Financial services and Insurance (BFSI). Our expertise are data triangulation, competitor benchmarking, parent market benchmarking, estimating market size and forecast of the market from 2016 to 2024.
For further information, visithttps://www.variantmarketresearch.com
You can connect with us on LinkedIn here @https://www.linkedin.com/company/variant-market-research
Contact Us:
Michael Mendes
Head - Sales
Variant Market Research
649 Mission St, 5th Floor, San Francisco, CA 94105, United States.
Tel: +1-415-680-2785
Fax: +1-415-680-2786

No comments:

Post a Comment

Global Depression Drug Market Is Boosted By Growing Awareness Regarding Depression

Global Depression Drug Market  Report , published by Variant Market Research, forecast that the global market was valued at $15 billion...